MaltSci 麦伴科研

Appearance

Popular Reports / microbiology

This report is written by MaltSci based on the latest literature and research findings

How do probiotics modulate immune function? ​

Abstract ​

Probiotics, defined as live microorganisms that confer health benefits to the host when administered in adequate amounts, have gained attention in the biomedical field for their potential to modulate immune function. The human gut microbiota plays a crucial role in maintaining immune homeostasis, and an imbalance can lead to various health issues, including autoimmune diseases and allergies. This review explores the mechanisms by which probiotics influence immune function, including their effects on gut microbiota composition, gut barrier integrity, cytokine production, and immune cell activity. Probiotics enhance the gut barrier by promoting mucus production and strengthening tight junctions, which prevents pathogen translocation and systemic inflammation. They also modulate the immune response by influencing cytokine profiles, promoting anti-inflammatory pathways, and activating immune cells such as macrophages and T lymphocytes. Specific strains, such as Lactobacillus and Bifidobacterium, have shown promise in enhancing immune responses, particularly in immunocompromised individuals and those with chronic inflammatory diseases. However, challenges remain in translating probiotic research into clinical practice, including strain specificity, dosage variability, and the need for standardization. Future research should focus on personalized probiotic therapies and addressing existing gaps in knowledge to optimize their therapeutic potential. By synthesizing current research and identifying key areas for exploration, this review provides valuable insights into the strategic use of probiotics to enhance immune health.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Immune Modulation by Probiotics
    • 2.1 Influence on Gut Microbiota Composition
    • 2.2 Enhancement of Gut Barrier Function
    • 2.3 Modulation of Cytokine Production
    • 2.4 Activation of Immune Cells
  • 3 Types of Probiotics and Their Specific Effects
    • 3.1 Lactobacillus Species
    • 3.2 Bifidobacterium Species
    • 3.3 Saccharomyces boulardii
    • 3.4 Multi-strain Probiotic Formulations
  • 4 Clinical Implications of Probiotic Use
    • 4.1 Probiotics in Immunocompromised Patients
    • 4.2 Probiotics in Chronic Inflammatory Diseases
    • 4.3 Probiotics in Allergy and Autoimmunity
  • 5 Challenges and Future Directions
    • 5.1 Current Research Gaps
    • 5.2 Standardization and Quality Control
    • 5.3 Personalized Probiotic Therapy
  • 6 Summary

1 Introduction ​

Probiotics, defined as live microorganisms that confer health benefits to the host when administered in adequate amounts, have emerged as a focal point of research within the biomedical field, particularly concerning their potential to modulate immune function. The human gut, which houses a complex and dynamic community of microorganisms, plays a pivotal role in maintaining homeostasis and influencing immune responses. The interaction between gut microbiota and the immune system is crucial for the development and regulation of immune functions, and an imbalance in this microbiota can lead to various health issues, including autoimmune diseases, allergies, and inflammatory conditions [1][2]. Given the rising prevalence of these conditions, understanding how probiotics can positively influence immune responses has significant implications for public health.

Research has shown that probiotics can enhance the host's immune system through various mechanisms. These include promoting the production of specific antibodies, modulating cytokine profiles, and enhancing the activity of immune cells such as macrophages and T lymphocytes [3][4]. Furthermore, probiotics can influence gut barrier function and microbiota composition, both of which are essential for a balanced immune response [5][6]. This modulation of immune function can be particularly beneficial in individuals who are immunocompromised or suffer from chronic inflammatory diseases, highlighting the therapeutic potential of probiotics in clinical settings [7][8].

The current state of research on probiotics reveals a growing body of evidence supporting their immunomodulatory effects. However, many studies have primarily focused on their metabolic and nutritional properties, leaving the mechanisms underlying the interaction between host immune cells and probiotics only partially understood [3][5]. The lack of clarity regarding specific strains and their effects on immune responses further complicates the translation of probiotic research into clinical practice [5][9]. As such, there is a pressing need for comprehensive reviews that synthesize existing knowledge and identify gaps in our understanding of probiotics and their immune-modulating effects.

This review aims to explore the mechanisms through which probiotics modulate immune function, categorized into several key areas. First, we will examine the influence of probiotics on gut microbiota composition, detailing how specific strains can alter the microbial landscape to favor beneficial organisms. Next, we will discuss the enhancement of gut barrier function and its implications for immune health. The modulation of cytokine production and the activation of immune cells will be explored in depth, highlighting the diverse ways in which probiotics can influence immune responses [3][4].

Subsequently, we will categorize the types of probiotics studied, including Lactobacillus and Bifidobacterium species, Saccharomyces boulardii, and multi-strain formulations, and outline their specific effects on immune function [5][9]. The clinical implications of these findings will also be addressed, particularly in relation to their use in immunocompromised patients, chronic inflammatory diseases, and allergy and autoimmunity [7][8].

Finally, we will discuss the challenges and future directions in probiotic research, emphasizing current research gaps, the need for standardization and quality control, and the potential for personalized probiotic therapies [2][8]. By synthesizing current research and identifying key areas for future exploration, this review will provide valuable insights into how probiotics can be strategically utilized to enhance immune health and address pressing health challenges.

2 Mechanisms of Immune Modulation by Probiotics ​

2.1 Influence on Gut Microbiota Composition ​

Probiotics are live microorganisms that confer health benefits to the host, particularly through their ability to modulate immune function. The mechanisms by which probiotics influence immune responses are multifaceted and primarily involve alterations in gut microbiota composition, which in turn affects the host's immune system.

One significant mechanism of immune modulation by probiotics is their capacity to enhance the gut epithelial barrier. Probiotics can increase the production of mucus and strengthen tight junction proteins, thereby reducing intestinal permeability and preventing the translocation of pathogens and toxins into the bloodstream. This is particularly important because a compromised gut barrier can lead to systemic inflammation and immune activation. For instance, probiotics have been shown to decrease the levels of lipopolysaccharides (LPS), which are potent stimulators of inflammatory responses when they bind to toll-like receptors (TLR) on immune cells, such as dendritic cells and macrophages[10].

Moreover, probiotics can alter the composition of the gut microbiota by promoting the growth of beneficial bacteria while inhibiting pathogenic organisms. This competitive exclusion helps to maintain a balanced microbiome, which is crucial for optimal immune function. Dysbiosis, or an imbalance in gut microbiota, is associated with various inflammatory and autoimmune diseases. By restoring microbial diversity, probiotics can enhance the production of short-chain fatty acids (SCFAs) and other metabolites that play critical roles in immune regulation[2].

Another mechanism involves the modulation of host microRNA (miRNA) expression. Probiotics can influence the expression of specific miRNAs that regulate immune responses, thereby enhancing the host's resistance to pathogens and modulating inflammation. This post-transcriptional regulation allows probiotics to fine-tune immune cell functions, promoting anti-inflammatory pathways while suppressing pro-inflammatory responses[2].

Probiotics also directly stimulate immune cells. They can enhance the activity of macrophages and natural killer (NK) cells, leading to increased phagocytosis and cytotoxic activity against pathogens. Additionally, probiotics modulate the secretion of immunoglobulins and cytokines, promoting a balanced immune response that is crucial for maintaining homeostasis[11].

Furthermore, the interaction between probiotics and the gut-associated lymphoid tissue (GALT) plays a vital role in immune modulation. Probiotics can activate GALT, leading to the differentiation of T-helper cells and the production of anti-inflammatory cytokines such as IL-10. This promotes a shift from a Th1/Th2 inflammatory response towards a more regulated immune profile, which is essential for preventing chronic inflammation and autoimmunity[9].

In summary, probiotics modulate immune function through various mechanisms, including enhancing gut barrier integrity, altering gut microbiota composition, regulating host miRNA expression, stimulating immune cell activity, and interacting with the GALT. These processes collectively contribute to improved immune responses and a reduction in inflammation, highlighting the therapeutic potential of probiotics in managing immune-related disorders.

2.2 Enhancement of Gut Barrier Function ​

Probiotics play a significant role in modulating immune function, particularly through their effects on gut barrier integrity. The gastrointestinal tract serves as a crucial interface between the human body and external agents, and its integrity is essential for maintaining immune homeostasis. Probiotics, defined as live microorganisms that confer health benefits to the host when consumed in adequate amounts, exert several mechanisms to enhance gut barrier function and, consequently, modulate immune responses.

One of the primary mechanisms by which probiotics enhance gut barrier function is by reinforcing tight junctions between intestinal epithelial cells. This reinforcement helps to maintain the structural integrity of the intestinal barrier, thereby preventing the translocation of pathogens and toxins into the systemic circulation. Probiotics achieve this by stimulating the expression of membrane-associated glycoproteins and promoting mucin production, which strengthens the mucus layer that protects the intestinal epithelium [12].

Furthermore, probiotics can inhibit pathogen adhesion and colonization by competing for binding sites on the intestinal epithelium and by producing antimicrobial metabolites such as bacteriocins and organic acids. This competitive exclusion not only protects the host from pathogenic microorganisms but also promotes a favorable microbial composition, which is vital for a balanced immune response [12].

Probiotics also play a role in modulating the immune system through their interaction with immune cells. They can enhance the activity of macrophages and natural killer cells, as well as influence the secretion of immunoglobulins and cytokines. This immunomodulatory effect is further supported by the ability of probiotics to alter the gut microbiota composition, leading to increased diversity and the enrichment of beneficial bacterial species, such as Bifidobacterium and Lactobacillus [13].

In a systematic review and meta-analysis of randomized controlled trials, it was found that probiotics significantly improve gut barrier function, as evidenced by increased transepithelial electrical resistance (TER) and decreased levels of serum zonulin and endotoxins. These changes indicate a more intact intestinal barrier, which correlates with reduced inflammation and improved immune responses [13].

Moreover, the production of short-chain fatty acids (SCFAs) during probiotic fermentation has been shown to have positive effects on gut health and immune modulation. SCFAs serve as energy sources for colonocytes and play a role in regulating inflammatory responses within the gut [9].

Overall, the mechanisms by which probiotics enhance gut barrier function include reinforcing epithelial integrity, stimulating mucin production, inhibiting pathogen adhesion, modulating immune cell activity, and altering the gut microbiota composition. These actions collectively contribute to improved immune function and a more resilient gut environment, highlighting the therapeutic potential of probiotics in managing immune-related conditions and maintaining overall health [9][12][13].

2.3 Modulation of Cytokine Production ​

Probiotics have been recognized for their significant role in modulating immune function, particularly through the regulation of cytokine production. The mechanisms by which probiotics exert these immunomodulatory effects are diverse and complex, involving various cellular pathways and immune mediators.

Probiotics can enhance or suppress the production of cytokines, which are critical signaling molecules in the immune system. They achieve this modulation through several mechanisms, including competitive exclusion of pathogens, direct interaction with immune cells, and alteration of gene expression related to immune responses.

One of the primary mechanisms is the interaction of probiotics with pattern recognition receptors (PRRs) on immune cells. For instance, specific probiotic strains such as Lactobacillus rhamnosus and Bifidobacterium breve have been shown to influence the production of pro-inflammatory cytokines like interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α), while also promoting the production of anti-inflammatory cytokines such as IL-10. This modulation of cytokine profiles can lead to a balanced immune response, promoting homeostasis and reducing the risk of inflammatory diseases[14][15].

Probiotics can also enhance the activity of various immune cells, including macrophages and dendritic cells. For example, the exposure of human peripheral blood mononuclear cells to probiotics results in increased secretion of both pro-inflammatory and anti-inflammatory cytokines, demonstrating their capacity to stimulate a robust immune response[16]. Additionally, probiotics have been shown to induce the differentiation of T helper type 17 (Th17) and regulatory T cells (Treg), which are essential for maintaining immune tolerance and regulating inflammation[17].

Another critical aspect of immune modulation by probiotics is their influence on microRNA (miRNA) expression. Probiotics can alter the expression levels of specific miRNAs, which are vital regulators of gene expression and play a significant role in immune function. By modulating miRNA expression, probiotics can affect the translation of mRNAs that encode for cytokines and other immune-related proteins, thereby influencing the overall immune response[2].

Moreover, the production of postbiotics, which are bioactive compounds derived from probiotics, has been linked to immune modulation. These postbiotics can interact with immune cells and promote cytokine production, further enhancing the immunomodulatory effects of probiotics[18].

In summary, probiotics modulate immune function through a multifaceted approach that includes direct interaction with immune cells, modulation of cytokine production, alteration of miRNA expression, and the generation of postbiotics. These mechanisms collectively contribute to the enhancement of the immune response, maintenance of immune homeostasis, and the prevention of inflammatory and autoimmune diseases[6][19].

2.4 Activation of Immune Cells ​

Probiotics exert significant effects on immune function through various mechanisms, particularly by modulating the activity and polarization of immune cells. These mechanisms can be broadly categorized into direct interactions with immune cells and indirect modulation through the gut microbiota.

One of the primary ways probiotics activate immune function is through their interaction with innate immune cells, such as macrophages and dendritic cells. Probiotic bacteria can influence macrophage polarization, shifting the balance between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes. Some probiotic strains are reported to activate macrophages towards the M1 phenotype, enhancing their ability to combat intracellular pathogens, while others promote the M2 phenotype, which is associated with tissue repair and anti-inflammatory responses [20]. This polarization is crucial for maintaining immune homeostasis and preventing excessive inflammation.

Furthermore, probiotics can enhance the activation of dendritic cells (DCs), which play a vital role in orchestrating the immune response. Probiotic strains, such as Lactobacillus gasseri, have been shown to modulate the maturation of DCs, leading to altered secretome profiles that include various immune mediators [21]. This interaction not only affects the local immune environment but also influences systemic immune responses by shaping T cell activation and differentiation.

Probiotics also interact with signaling pathways that regulate immune cell activation. They can modulate pathways associated with Toll-like receptors (TLRs), which are critical for pathogen recognition and the initiation of immune responses [22]. By influencing these pathways, probiotics can enhance the production of cytokines and other signaling molecules that facilitate immune activation and coordination [4].

Moreover, probiotics can stimulate the secretion of immunomodulatory proteins, lipids, and metabolites, which contribute to the overall immune response [4]. These metabolites, including short-chain fatty acids produced during fermentation, can have systemic effects on immune cell function and inflammation [9].

In addition to their effects on innate immunity, probiotics also impact adaptive immune responses. They can enhance the function of B cells, which are essential for antibody production and immune memory [7]. This effect is particularly important in the context of managing allergies and autoimmune diseases, where a balanced immune response is critical.

Overall, the immunomodulatory effects of probiotics are complex and involve a combination of direct interactions with immune cells, modulation of signaling pathways, and the production of beneficial metabolites. These mechanisms highlight the potential of probiotics as therapeutic agents in enhancing immune function and managing various immune-related conditions.

3 Types of Probiotics and Their Specific Effects ​

3.1 Lactobacillus Species ​

Probiotics, particularly those belonging to the Lactobacillus genus, play a significant role in modulating immune function through various mechanisms. The immunomodulatory effects of probiotics are largely strain-specific and can vary depending on the probiotic species involved.

Lactobacillus species, such as Lactobacillus rhamnosus, Lactobacillus casei, and Lactobacillus gasseri, have been extensively studied for their ability to enhance immune responses. These probiotics are known to stimulate both innate and adaptive immunity, promoting the activation of immune cells such as macrophages, natural killer (NK) cells, and T lymphocytes. For instance, Lactobacillus rhamnosus GG has been shown to enhance nonspecific cellular immune responses characterized by the activation of macrophages and NK cells, as well as the release of various cytokines in a strain-specific and dose-dependent manner[15].

The mechanisms by which Lactobacillus species exert their immunomodulatory effects include the modulation of dendritic cell (DC) function and signaling pathways. For example, a study on Lactobacillus gasseri demonstrated its ability to modulate dendritic cell maturation and the secretion of various immune mediators. This modulation is critical as dendritic cells play a pivotal role in orchestrating immune responses[21]. Additionally, Lactobacillus johnsonii has been reported to enhance the expression of pro-inflammatory mediators and toll-like receptor (TLR) pathways in intestinal epithelial cells, further illustrating the complex interactions between probiotics and the immune system[23].

Lactobacillus species can also influence the balance of T helper cell responses. Research has shown that certain strains can skew the immune response towards a T helper 1 (Th1) polarization, characterized by increased production of interferon-gamma (IFN-γ) and interleukin-12 (IL-12) while suppressing Th2 responses associated with allergic reactions[24]. This shift is particularly beneficial in managing allergic conditions and other immune-mediated diseases.

Moreover, the secretion of immunomodulatory substances, such as cytokines and other signaling molecules, by Lactobacillus species contributes to their protective effects against pathogens and inflammatory diseases. For instance, Lactobacillus plantarum has been noted for its ability to enhance interleukin-10 (IL-10) secretion from antigen-presenting cells, which is crucial for reducing inflammation and promoting a tolerogenic immune environment[25].

The interaction between probiotics and the host's immune system is multifaceted, involving direct contact with immune cells and indirect modulation through the gut microbiota. Probiotics like Lactobacillus can alter the gut microbiota composition, leading to enhanced mucosal immunity and improved gut barrier function, which further protects against pathogenic infections and inflammation[4].

In summary, Lactobacillus species exert their immunomodulatory effects through various mechanisms, including the activation of immune cells, modulation of cytokine production, and the regulation of signaling pathways involved in immune responses. These effects contribute to their potential therapeutic roles in preventing and managing immune-related disorders.

3.2 Bifidobacterium Species ​

Probiotics, particularly members of the Bifidobacterium genus, have been extensively studied for their immunomodulatory effects, which play a crucial role in maintaining immune homeostasis and combating various diseases. Bifidobacterium species are known to possess several mechanisms through which they modulate immune function, impacting both innate and adaptive immune responses.

Bifidobacterium acts primarily by interacting with the host's immune system, enhancing the activity of various immune cells and influencing cytokine production. For instance, it has been demonstrated that Bifidobacterium can upregulate the production of regulatory T cells, which are essential for maintaining immune tolerance and preventing autoimmune responses. This regulatory effect is significant, as depletion or absence of Bifidobacterium in humans and model organisms is associated with autoimmune conditions and impaired immune homeostasis [26].

The immunomodulatory effects of Bifidobacterium can be attributed to several specific actions. These include the modulation of dendritic cell and macrophage activity, maintenance of intestinal barrier function, and dampening of Th2 and Th17 immune programs. Recent studies have highlighted that Bifidobacterium can produce surface structural polysaccharides and proteins, along with various metabolic products that act as mediators of immune homeostasis [26].

In terms of specific strains, research has shown that different Bifidobacterium species can exert distinct immunomodulatory effects. For example, Bifidobacterium adolescentis and Bifidobacterium longum subsp. infantis have been shown to influence cytokine signaling pathways differently in the context of gut immunity. In a study utilizing a DSS-induced chronic colitis mouse model, these strains were found to modulate immune activation markers and cytokine production, affecting the levels of γδ T cells in peripheral blood and colorectal tissues [27].

Furthermore, the interaction of Bifidobacterium with other microbial species in the gut can also influence immune responses. The presence of Bifidobacterium in the microbiota has been associated with a more diverse and stable gut microbiome, which is critical for effective immune function. This highlights the importance of maintaining a balanced gut microbiota for optimal immune health [26].

The immunomodulatory properties of Bifidobacterium extend beyond just the gut. For instance, in a study on the prophylactic effects of Bifidobacterium bifidum against influenza infection in mice, it was found to enhance both humoral and cellular immune responses, indicating its potential to modulate systemic immune functions [28]. This systemic effect is particularly relevant in the context of respiratory infections and allergies, where Bifidobacterium has shown promise in alleviating symptoms and improving overall immune response [29].

In summary, Bifidobacterium species play a vital role in modulating immune function through various mechanisms, including enhancing regulatory T cell activity, modulating dendritic cell and macrophage functions, and influencing cytokine production. These effects underscore the potential of Bifidobacterium as a therapeutic agent in managing immune-related disorders and promoting overall health. The ongoing research continues to elucidate the specific pathways and interactions involved, paving the way for personalized probiotic interventions aimed at optimizing immune health across different life stages [26][27].

3.3 Saccharomyces boulardii ​

Probiotics, particularly Saccharomyces boulardii, have been extensively studied for their role in modulating immune function. S. boulardii is a probiotic yeast that exhibits various mechanisms through which it influences the immune response, thereby providing protective effects against gastrointestinal disorders and inflammation.

One of the primary ways S. boulardii modulates immune function is through the alteration of cytokine secretion. In a study by Fidan et al. (2009), it was observed that S. boulardii decreased the secretion of pro-inflammatory cytokines, such as interleukin (IL)-1beta, from intraepithelial lymphocytes infected with pathogens like Escherichia coli and Candida albicans. Conversely, it increased the levels of anti-inflammatory cytokines such as IL-4 and IL-10, suggesting a shift towards a more anti-inflammatory immune response[30].

Moreover, S. boulardii has been shown to inhibit the activation of dendritic cells (DCs), which play a crucial role in the initiation and regulation of immune responses. Thomas et al. (2009) demonstrated that S. boulardii significantly reduced the expression of co-stimulatory molecules (CD40 and CD80) and the mobilization marker CCR7 on DCs, which are critical for T cell activation. This reduction was accompanied by a decrease in the secretion of pro-inflammatory cytokines like tumor necrosis factor-alpha and IL-6, while IL-10 levels increased, indicating an anti-inflammatory effect[31].

In addition to cytokine modulation, S. boulardii enhances the production of secretory immunoglobulin A (sIgA), which is vital for mucosal immunity. Rodrigues et al. (2000) reported that S. boulardii administration in gnotobiotic mice led to increased sIgA production, suggesting that this probiotic may strengthen the mucosal barrier and enhance the immune response against enteropathogenic bacteria[32].

Furthermore, S. boulardii exhibits protective effects through the gut-liver axis, where it can influence liver inflammation and function. Cui et al. (2022) reviewed the therapeutic potential of S. boulardii in liver diseases, highlighting its role in immune regulation and its capacity to produce antimicrobial substances, thereby maintaining gut barrier integrity and exerting antioxidant effects[33].

The modulation of the gut microbiota is another crucial aspect of how S. boulardii affects immune function. Research indicates that S. boulardii can enhance the diversity of gut microbiota and promote the growth of beneficial bacteria, which can contribute to a balanced immune response. For instance, in a study focusing on dextran sulfate sodium (DSS)-induced colitis, S. boulardii was found to regulate inflammatory responses and alter microbiome composition, which was associated with improved gut health and reduced inflammation[34].

Overall, S. boulardii acts as a multifaceted probiotic that modulates immune function through various pathways, including cytokine secretion, dendritic cell activity, sIgA production, and gut microbiota composition. These mechanisms collectively contribute to its efficacy in managing gastrointestinal diseases and inflammatory conditions, highlighting its potential as a therapeutic agent in immunomodulation.

3.4 Multi-strain Probiotic Formulations ​

Probiotics are live microorganisms that confer health benefits to the host, particularly through their ability to modulate immune function. This modulation occurs via various mechanisms, and the effects can vary significantly depending on the type of probiotic strain used.

Probiotics can interact with immune cells and influence immune responses in several ways. They can enhance the intestinal mucosal barrier, inhibit pathogen adhesion, stimulate immune modulation, and foster the production of beneficial substances [2]. For instance, specific strains of Lactobacillus and Bifidobacterium have been shown to enhance both innate and adaptive immunity, thereby improving the host's defense against infections and inflammatory conditions [17].

Different types of probiotics may act as immune activators or suppressors. Some probiotics enhance the activity of immune cells such as macrophages and dendritic cells, promoting a robust immune response, while others may induce a more tolerogenic environment, reducing inflammation [4]. For example, probiotics can modulate macrophage polarization, shifting them towards an M1 phenotype to enhance pro-inflammatory responses or an M2 phenotype to promote anti-inflammatory effects [20].

Multi-strain probiotic formulations can provide a synergistic effect, where the combination of different strains enhances the overall immunomodulatory response. This is due to the diverse mechanisms through which each strain operates, potentially leading to improved outcomes compared to single-strain probiotics. Research indicates that multi-strain formulations can better balance immune activation and suppression, making them particularly useful in managing conditions such as allergies, autoimmune diseases, and inflammatory bowel disease [8].

In summary, probiotics modulate immune function through complex interactions with immune cells, influencing pathways that regulate inflammation and immune responses. Multi-strain formulations leverage the strengths of various probiotic strains to provide a more comprehensive approach to immune modulation, potentially leading to enhanced health benefits.

4 Clinical Implications of Probiotic Use ​

4.1 Probiotics in Immunocompromised Patients ​

Probiotics are live microorganisms that confer health benefits when consumed in adequate amounts, primarily through their ability to modulate immune function. The mechanisms by which probiotics exert their immunomodulatory effects are multifaceted, involving direct interactions with immune cells, modulation of gut microbiota, and the production of bioactive compounds.

Probiotics enhance the intestinal barrier function, which is crucial for maintaining immune homeostasis. They achieve this by promoting the integrity of tight junctions between epithelial cells, thereby reducing intestinal permeability and preventing the translocation of pathogens and toxins into the bloodstream. A systematic review and meta-analysis involving 26 randomized controlled trials indicated that probiotics significantly improved gut barrier function, as evidenced by increased levels of transepithelial electrical resistance (TER) and decreased serum zonulin levels, which are markers of intestinal permeability [13].

Furthermore, probiotics have been shown to influence the expression of various cytokines and immune mediators. They can stimulate the production of anti-inflammatory cytokines while inhibiting pro-inflammatory cytokines, thus helping to balance immune responses. For instance, probiotic administration has been associated with reductions in inflammatory markers such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) [13].

Probiotics also modulate the gut microbiota composition, enhancing the growth of beneficial bacteria like Lactobacillus and Bifidobacterium while suppressing pathogenic species. This shift in microbiota can lead to improved immune responses, as a diverse and balanced microbiota is essential for optimal immune function [5].

Another critical mechanism involves the regulation of host microRNAs (miRNAs), which are non-coding RNA molecules that play vital roles in gene expression and immune modulation. Probiotics can alter the expression levels of specific miRNAs, thereby influencing the immune system's response to pathogens and the overall immune landscape [2].

In the context of immunocompromised patients, the use of probiotics may provide therapeutic benefits by enhancing immune function and reducing the risk of infections. However, the clinical implications must be approached with caution, as these patients may be more susceptible to infections, including those caused by the very microorganisms present in probiotic formulations. Clinical trials have shown variable outcomes regarding the efficacy of probiotics in such populations, emphasizing the need for tailored probiotic interventions based on individual patient profiles [35].

In summary, probiotics modulate immune function through several mechanisms, including strengthening the intestinal barrier, regulating cytokine production, modifying gut microbiota composition, and influencing miRNA expression. These effects hold significant clinical implications, particularly for immunocompromised patients, where careful consideration of probiotic use is essential to optimize health outcomes while minimizing risks. Further research is warranted to clarify the specific strains and dosages that are most effective in these populations, as well as to establish guidelines for safe and effective probiotic use in clinical practice.

4.2 Probiotics in Chronic Inflammatory Diseases ​

Probiotics are live microorganisms that confer health benefits to the host when administered in adequate amounts, primarily through their role in modulating immune function and promoting gut health. Their therapeutic potential is particularly significant in the context of chronic inflammatory diseases, where they can help restore balance to the gut microbiota and mitigate inflammation.

Probiotics exert their immunomodulatory effects through several mechanisms. Firstly, they can enhance the diversity of gut microbiota, which is crucial for maintaining a balanced immune response. By increasing microbial diversity, probiotics help restore gut homeostasis, which is often disrupted in conditions like inflammatory bowel disease (IBD) and other chronic inflammatory disorders. For instance, chronic intestinal conditions are characterized by decreased microbiota diversity and persistent inflammation, which can lead to mucosal damage. Probiotics have been shown to improve gut microbiota composition and promote wound healing, thereby shaping the immunological responses in the gut [36].

Secondly, probiotics interact with the host's immune system in multiple ways. They can displace potential pathogens through competitive exclusion, offer protection via the secretion of various defensive mediators, and supply essential nutrients to the host. This multifaceted approach helps to modulate the inflammatory response, as seen in studies where probiotics have reduced systemic inflammation markers such as TNF-α and IL-6 [37].

In the context of chronic inflammatory diseases, probiotics have shown promise in managing conditions like IBD. They can modulate immune responses by regulating cytokine production and enhancing mucosal barrier integrity. Specific strains, such as those from the Bifidobacterium and Lactobacillus genera, have been particularly effective in improving clinical symptoms and histological alterations associated with chronic intestinal inflammation [38]. Clinical evidence suggests that probiotics can provide measurable health advantages, particularly in patients with IBD, by ameliorating symptoms and potentially preventing relapses [39].

Moreover, probiotics are also recognized for their role in the gut-brain axis, where they can influence behavior and cognitive function through immune modulation. This connection highlights their potential therapeutic applications beyond gastrointestinal health, extending to neurological and mental health disorders [40].

The implications of these findings for clinical practice are significant. Probiotics can be considered as adjunctive therapies in the management of chronic inflammatory diseases, providing a safe and effective strategy to modulate immune responses and improve patient outcomes. However, it is essential to note that while the benefits of probiotics are promising, further research is needed to fully understand the mechanisms by which they exert their effects and to identify the most effective strains and dosages for specific conditions [36][38].

In summary, probiotics modulate immune function by enhancing gut microbiota diversity, regulating immune responses, and improving mucosal integrity, making them a valuable tool in the management of chronic inflammatory diseases. Their therapeutic potential continues to be explored, offering hope for improved management strategies in clinical settings.

4.3 Probiotics in Allergy and Autoimmunity ​

Probiotics are live microorganisms that confer health benefits to the host, particularly in modulating immune function. Their mechanisms of action involve complex interactions with the gut microbiota and the immune system, leading to beneficial effects on various health conditions, including allergies and autoimmune diseases.

Probiotics enhance immune function primarily through the modulation of immune cell activity and the gut microbiota composition. They can strengthen the intestinal mucosal barrier, inhibit pathogen adhesion, and stimulate immune responses, which collectively help maintain immune homeostasis. For instance, probiotics have been shown to increase the production of secretory immunoglobulin A (sIgA) and enhance the activity of T cells, natural killer cells, and macrophages, which are crucial for effective immune responses[2][4].

The immunomodulatory effects of probiotics are also linked to their ability to regulate the expression of host microRNAs (miRNAs). These non-coding RNA molecules play a critical role in the post-transcriptional regulation of gene expression, influencing immune responses by either promoting the degradation of target mRNAs or repressing their translation. By modulating miRNA expression, probiotics can alter the immune system's sensitivity to pathogens and the overall inflammatory response[2].

In the context of allergy and autoimmunity, probiotics can help mitigate symptoms and improve outcomes. Allergic conditions often arise from an imbalance in immune responses, where Th2-type immune responses dominate. Probiotics, particularly strains of Lactobacillus and Bifidobacterium, have been demonstrated to shift the immune response towards a more balanced Th1/Th2 ratio, thereby reducing the severity of allergic reactions[3][29]. Additionally, they can enhance the production of anti-inflammatory cytokines such as IL-10, which plays a protective role in allergic and autoimmune diseases[6].

Probiotics also contribute to the restoration of gut microbiota eubiosis, which is often disrupted in individuals with autoimmune conditions. This restoration can help modulate systemic inflammation and immune dysregulation associated with these diseases[13][41]. For example, studies have shown that probiotics can reduce the incidence of allergic conditions in infants when administered to mothers during pregnancy and breastfeeding[42].

Moreover, probiotics have been investigated for their potential in treating various autoimmune diseases by supporting immune tolerance and reducing inflammation. By enhancing the gut barrier function and modulating immune responses, probiotics may help alleviate the symptoms of conditions such as inflammatory bowel disease and multiple sclerosis[19][43].

In summary, probiotics modulate immune function through various mechanisms, including the enhancement of gut barrier integrity, regulation of immune cell activity, modulation of miRNA expression, and restoration of gut microbiota balance. These actions contribute to their therapeutic potential in managing allergies and autoimmune diseases, making probiotics a promising adjunctive treatment option in clinical practice. Further high-quality clinical trials are necessary to fully elucidate the mechanisms and confirm the efficacy of probiotics in these contexts[2][13].

5 Challenges and Future Directions ​

5.1 Current Research Gaps ​

Probiotics are live microorganisms that confer health benefits to the host, particularly through their immunomodulatory effects. The mechanisms by which probiotics modulate immune function are complex and multifaceted, involving direct interactions with immune cells, alterations in gut microbiota composition, and the production of bioactive compounds.

One of the primary ways probiotics exert their immunomodulatory effects is by enhancing the intestinal barrier function. This is achieved through the secretion of protective factors that strengthen epithelial integrity, thereby preventing pathogen invasion and reducing inflammation. Probiotics can also inhibit pathogen adhesion and colonization, promoting the growth of beneficial gut microbes and modulating immune responses. For instance, Lactobacillus and Bifidobacterium species have been shown to activate signaling pathways that lead to enhanced immune homeostasis and tolerance [5].

The interaction between probiotics and the host immune system involves a complex network of pathways that facilitate communication between immune cells and commensal microbes. Probiotics can stimulate specific immune functions by engaging with various immune cell types, including dendritic cells, T cells, and B cells. These interactions can lead to the production of anti-inflammatory cytokines and the modulation of immune responses toward a more balanced state [3].

Despite the promising effects of probiotics on immune function, current research faces several challenges and gaps. Many clinical studies have yielded conflicting results, which may stem from the heterogeneity of probiotic strains used, variations in dosages, and differences in study designs. Additionally, the specific mechanisms through which probiotics influence immune cells remain inadequately understood. For example, while some studies have highlighted the role of bacterial cell wall components as effector molecules in mediating these interactions, the precise pathways and outcomes are still under investigation [5].

Future research should focus on elucidating the molecular mechanisms underlying the immunomodulatory effects of probiotics. This includes identifying specific probiotic components that mediate these effects, understanding the impact of different strains on immune responses, and exploring the potential for personalized probiotic therapies based on individual microbiota profiles. Moreover, there is a need for well-designed clinical trials that can reliably assess the immunological outcomes of probiotic interventions in diverse populations [2].

In conclusion, while probiotics hold significant potential for modulating immune function and improving health outcomes, further research is essential to overcome existing challenges and fully harness their therapeutic benefits. By addressing current gaps in knowledge and understanding the intricacies of probiotic-host interactions, future studies can pave the way for effective applications of probiotics in clinical practice [9].

5.2 Standardization and Quality Control ​

Probiotics play a significant role in modulating immune function through various mechanisms that influence the gut microbiota and the host's immune responses. Probiotics, defined as live microorganisms that confer health benefits to the host, can enhance immune responses by promoting the growth of beneficial bacteria, modifying immune cell activity, and maintaining the integrity of the gut barrier. Specifically, probiotics have been shown to increase the activity of immune cells and the production of anti-inflammatory cytokines, which are crucial for a balanced immune response[9].

The modulation of immune function by probiotics can be observed through their effects on both humoral and cellular immunity. For instance, they can enhance the mucosal immune system, influencing the production of antibodies and the activity of various immune cells, including macrophages and T-cells[44]. This immunomodulatory effect is particularly important in the context of diseases where immune function is compromised or dysregulated.

Despite the promising benefits of probiotics, several challenges remain in their clinical application. One of the primary issues is the variability in the efficacy of different probiotic strains, which can be influenced by factors such as dosage, duration of administration, and individual host characteristics[45]. Additionally, the mechanisms by which probiotics exert their effects are not fully understood, necessitating further research to elucidate these pathways and to identify the specific probiotic strains that are most effective for particular health outcomes[46].

Future directions in probiotic research should focus on standardization and quality control of probiotic products. Ensuring the viability and potency of probiotics throughout their shelf life is critical for achieving the desired health benefits. This involves rigorous quality assurance measures during manufacturing and storage, as well as clear labeling of probiotic content and potency[47]. Furthermore, there is a need for well-designed clinical trials to establish the effectiveness of probiotics in various populations and to better understand their role in immune modulation.

In conclusion, while probiotics offer a promising approach to enhancing immune function and improving health outcomes, addressing the challenges of strain variability, understanding their mechanisms of action, and implementing standardization and quality control measures are essential steps for their successful clinical application.

5.3 Personalized Probiotic Therapy ​

Probiotics, defined as live microorganisms that confer health benefits to the host, play a significant role in modulating immune function through various mechanisms. Their effects on the immune system are complex and multifaceted, influencing both innate and adaptive immunity.

Probiotics interact with the host's immune system primarily through the gut, where they help maintain the integrity of the intestinal barrier and promote a balanced immune response. They enhance the production of immunoglobulin A (IgA), a critical component of mucosal immunity, which plays a protective role against pathogens. Probiotics also influence the secretion of anti-inflammatory cytokines, thereby helping to control inflammatory responses in the gut. For instance, certain probiotic strains have been shown to modulate the activity of immune cells such as T lymphocytes and macrophages, leading to an improved immune profile and enhanced resistance to infections [48].

Moreover, probiotics can alter the gut microbiota composition, fostering a diverse microbial ecosystem that supports immune function. This alteration can inhibit the colonization of pathogenic bacteria, thereby reducing the risk of infections and diseases associated with dysbiosis [49]. The interplay between probiotics and the immune system is further mediated through the recognition of microbial patterns by Toll-like receptors (TLRs) on intestinal epithelial cells, which initiates signaling cascades that enhance immune responses [50].

Despite the promising potential of probiotics in modulating immune function, several challenges remain. One significant hurdle is the variability in the effects of different probiotic strains, which can lead to inconsistent outcomes in clinical applications [46]. Furthermore, the mechanisms underlying these effects are not fully understood, necessitating more in-depth research to elucidate the specific pathways involved [51].

As the field of probiotics evolves, there is a notable shift towards personalized probiotic therapy. This approach aims to tailor probiotic interventions based on individual microbiome profiles, genetic backgrounds, and specific health conditions. Personalized probiotics could potentially optimize therapeutic efficacy by ensuring that the selected strains align with the unique needs of each patient [52]. However, the implementation of personalized probiotic therapies faces challenges, including the need for standardized protocols for strain selection and a robust framework for clinical validation [53].

In conclusion, probiotics hold significant promise for modulating immune function and enhancing health outcomes. Future research should focus on unraveling the complexities of probiotic mechanisms, establishing standardized guidelines for strain selection, and validating personalized approaches in clinical settings. By addressing these challenges, the field can better harness the therapeutic potential of probiotics in improving immune health and preventing disease.

6 Conclusion ​

The exploration of probiotics and their ability to modulate immune function has unveiled significant insights into their therapeutic potential. Key findings indicate that probiotics enhance gut barrier integrity, modulate cytokine production, and stimulate immune cell activity, contributing to improved immune responses. Current research highlights the role of specific strains, such as Lactobacillus and Bifidobacterium, in promoting health and managing immune-related disorders. However, the variability in probiotic efficacy and the complexities of host-microbe interactions present challenges that necessitate further investigation. Future research should focus on elucidating the specific mechanisms of action, establishing standardized protocols for strain selection, and exploring personalized probiotic therapies tailored to individual microbiome profiles. By addressing these gaps, the field can better leverage the benefits of probiotics in clinical practice, ultimately enhancing immune health and addressing the rising prevalence of autoimmune diseases, allergies, and chronic inflammatory conditions.

References ​

  • [1] Julio Plaza-Diaz;Carolina Gomez-Llorente;Luis Fontana;Angel Gil. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.. World journal of gastroenterology(IF=5.4). 2014. PMID:25400447. DOI: 10.3748/wjg.v20.i42.15632.
  • [2] Wenjing Li;Yongwei Zeng;Jiayu Zhong;Youyu Hu;Xia Xiong;Yingshun Zhou;Li Fu. Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs.. Probiotics and antimicrobial proteins(IF=4.4). 2025. PMID:39754704. DOI: 10.1007/s12602-024-10443-9.
  • [3] Chiara Mazziotta;Mauro Tognon;Fernanda Martini;Elena Torreggiani;John Charles Rotondo. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health.. Cells(IF=5.2). 2023. PMID:36611977. DOI: 10.3390/cells12010184.
  • [4] Amy Llewellyn;Andrew Foey. Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events.. Nutrients(IF=5.0). 2017. PMID:29065562. DOI: 10.3390/nu9101156.
  • [5] Choong-Gu Lee;Kwang Hyun Cha;Gi-Cheon Kim;Sin-Hyeog Im;Ho-Keun Kwon. Exploring probiotic effector molecules and their mode of action in gut-immune interactions.. FEMS microbiology reviews(IF=12.3). 2023. PMID:37541953. DOI: 10.1093/femsre/fuad046.
  • [6] Bahman Yousefi;Majid Eslami;Abdolmajid Ghasemian;Parviz Kokhaei;Amir Salek Farrokhi;Narges Darabi. Probiotics importance and their immunomodulatory properties.. Journal of cellular physiology(IF=4.0). 2019. PMID:30317594. DOI: 10.1002/jcp.27559.
  • [7] Ran Wang;Yifei F Yu;Weiru R Yu;Siyuan Y Sun;Yumei M Lei;Yixuan X Li;Chenxu X Lu;Jianan N Zhai;Feirong R Bai;Fazheng Ren;Jiaqiang Q Huang;Juan Chen. Roles of Probiotics, Prebiotics, and Postbiotics in B-Cell-Mediated Immune Regulation.. The Journal of nutrition(IF=3.8). 2025. PMID:39551357. DOI: 10.1016/j.tjnut.2024.11.011.
  • [8] Yutong Xue;Mingyang Hu;Sina Cha;Chenyu Xue;Na Dong. Precision therapeutics for inflammatory bowel disease using engineered probiotics: Strategies and optimization.. Acta biomaterialia(IF=9.6). 2025. PMID:41083038. DOI: 10.1016/j.actbio.2025.10.012.
  • [9] Pengjun Zhou;Chunlan Chen;Sandip Patil;Shaowei Dong. Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony.. Frontiers in nutrition(IF=5.1). 2024. PMID:38389798. DOI: 10.3389/fnut.2024.1355542.
  • [10] Fernanda Cristofori;Vanessa Nadia Dargenio;Costantino Dargenio;Vito Leonardo Miniello;Michele Barone;Ruggiero Francavilla. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.. Frontiers in immunology(IF=5.9). 2021. PMID:33717063. DOI: 10.3389/fimmu.2021.578386.
  • [11] Giorgio La Fata;Peter Weber;M Hasan Mohajeri. Probiotics and the Gut Immune System: Indirect Regulation.. Probiotics and antimicrobial proteins(IF=4.4). 2018. PMID:28861741. DOI: 10.1007/s12602-017-9322-6.
  • [12] José Mercado-Monroy;Reyna Nallely Falfán-Cortés;Victor Manuel Muñóz-Pérez;Carlos Alberto Gómez-Aldapa;Javier Castro-Rosas. Probiotics as modulators of intestinal barrier integrity and immune homeostasis: a comprehensive review.. Journal of the science of food and agriculture(IF=3.5). 2025. PMID:40937527. DOI: 10.1002/jsfa.70168.
  • [13] Yanfei Zheng;Zengliang Zhang;Ping Tang;Yuqi Wu;Anqi Zhang;Delong Li;Chong-Zhi Wang;Jin-Yi Wan;Haiqiang Yao;Chun-Su Yuan. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials.. Frontiers in immunology(IF=5.9). 2023. PMID:37168869. DOI: 10.3389/fimmu.2023.1143548.
  • [14] Theo S Plantinga;Jeroen van Bergenhenegouwen;Cor Jacobs;Leo A B Joosten;Belinda van't Land;Johan Garssen;Mihai G Netea. Modulation of Toll-like receptor ligands and Candida albicans-induced cytokine responses by specific probiotics.. Cytokine(IF=3.7). 2012. PMID:22521032. DOI: 10.1016/j.cyto.2012.03.020.
  • [15] Rabia Ashraf;Nagendra P Shah. Immune system stimulation by probiotic microorganisms.. Critical reviews in food science and nutrition(IF=8.8). 2014. PMID:24499072. DOI: 10.1080/10408398.2011.619671.
  • [16] O N Donkor;M Ravikumar;O Proudfoot;S L Day;V Apostolopoulos;G Paukovics;T Vasiljevic;S L Nutt;H Gill. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure.. Clinical and experimental immunology(IF=3.8). 2012. PMID:22236005. DOI: 10.1111/j.1365-2249.2011.04496.x.
  • [17] Seyed-Alireza Esmaeili;Mahmoud Mahmoudi;Amir Abbas Momtazi;Amirhossein Sahebkar;Hassan Doulabi;Maryam Rastin. Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus.. Journal of cellular physiology(IF=4.0). 2017. PMID:27996081. DOI: 10.1002/jcp.25748.
  • [18] Kyle D Roberts;Sadia Ahmed;Erin San Valentin;Luca Di Martino;Thomas S McCormick;Mahmoud A Ghannoum. Immunomodulatory Properties of Multi-Strain Postbiotics on Human CD14+ Monocytes.. Life (Basel, Switzerland)(IF=3.4). 2024. PMID:39768380. DOI: 10.3390/life14121673.
  • [19] V B M Peters;E van de Steeg;J van Bilsen;M Meijerink. Mechanisms and immunomodulatory properties of pre- and probiotics.. Beneficial microbes(IF=3.1). 2019. PMID:30827150. DOI: 10.3920/BM2018.0066.
  • [20] Yang Wang;Huawei Liu;Jinshan Zhao. Macrophage Polarization Induced by Probiotic Bacteria: a Concise Review.. Probiotics and antimicrobial proteins(IF=4.4). 2020. PMID:31741313. DOI: 10.1007/s12602-019-09612-y.
  • [21] Maria Fiorella Mazzeo;Diomira Luongo;Toshihiro Sashihara;Mauro Rossi;Rosa Anna Siciliano. Secretome Analysis of Mouse Dendritic Cells Interacting with a Probiotic Strain of Lactobacillus gasseri.. Nutrients(IF=5.0). 2020. PMID:32093322. DOI: 10.3390/nu12020555.
  • [22] Angélica Vincenzi;Márcia Inês Goettert;Claucia Fernanda Volken de Souza. An evaluation of the effects of probiotics on tumoral necrosis factor (TNF-α) signaling and gene expression.. Cytokine & growth factor reviews(IF=11.8). 2021. PMID:33162326. DOI: 10.1016/j.cytogfr.2020.10.004.
  • [23] Stephanie Seifert;Manuel Rodriguez Gómez;Bernhard Watzl;Wilhelm H Holzapfel;Charles M A P Franz;María G Vizoso Pinto. Differential Effect of Lactobacillus johnsonii BFE 6128 on Expression of Genes Related to TLR Pathways and Innate Immunity in Intestinal Epithelial Cells.. Probiotics and antimicrobial proteins(IF=4.4). 2010. PMID:26781315. DOI: 10.1007/s12602-010-9055-2.
  • [24] Lisa Chuang;Keh-Gong Wu;Cindy Pai;Pei-Shan Hsieh;Jaw-Ji Tsai;Jyh-Herng Yen;Meei-Yn Lin. Heat-killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-treated T cells.. Journal of agricultural and food chemistry(IF=6.2). 2007. PMID:18038979. DOI: 10.1021/jf071786o.
  • [25] Kyeong Eun Hyung;Hyui Kyeong Yoo;Ju Eon Ham;Jee Yeon Choi;Sanggyu Lee;So-Young Park;Kwang Woo Hwang. Lactobacillus plantarum isolated from kimchi regulates inflammation by increasing interleukin-10 secretion by antigen-presenting cells, leading to diminishing of STAT5 phosphorylation in Th2 cells.. Journal of food science(IF=3.4). 2024. PMID:38685880. DOI: 10.1111/1750-3841.17082.
  • [26] Samuel J Gavzy;Allison Kensiski;Zachariah L Lee;Emmanuel F Mongodin;Bing Ma;Jonathan S Bromberg. Bifidobacterium mechanisms of immune modulation and tolerance.. Gut microbes(IF=11.0). 2023. PMID:38055306. DOI: 10.1080/19490976.2023.2291164.
  • [27] Yaqin He;Furui Zhang;Zhiqiang Tian;Ruyi Li;Ming Su;Liping Hong;Jun Wen;Cao Zhang;Jinhai Tian;Le Guo. Immune microenvironment-dependent effects of age-associated Bifidobacterium strains on gut immunity and microbial diversity.. Frontiers in cellular and infection microbiology(IF=4.8). 2025. PMID:41036227. DOI: 10.3389/fcimb.2025.1639178.
  • [28] Mehran Mahooti;Elahe Abdolalipour;Ali Salehzadeh;Seyed Reza Mohebbi;Ali Gorji;Amir Ghaemi. Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice.. World journal of microbiology & biotechnology(IF=4.2). 2019. PMID:31161259. DOI: 10.1007/s11274-019-2667-0.
  • [29] Igori Balta;Eugenia Butucel;Valentyn Mohylyuk;Adriana Criste;Daniel Severus Dezmirean;Lavinia Stef;Ioan Pet;Nicolae Corcionivoschi. Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities.. Diseases (Basel, Switzerland)(IF=3.0). 2021. PMID:34562967. DOI: 10.3390/diseases9030060.
  • [30] Isil Fidan;Ayse Kalkanci;Emine Yesilyurt;Burce Yalcin;Berna Erdal;Semra Kustimur;Turgut Imir. Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans.. Mycoses(IF=3.1). 2009. PMID:18627477. DOI: 10.1111/j.1439-0507.2008.01545.x.
  • [31] S Thomas;I Przesdzing;D Metzke;J Schmitz;A Radbruch;D C Baumgart. Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.. Clinical and experimental immunology(IF=3.8). 2009. PMID:19161443. DOI: 10.1111/j.1365-2249.2009.03878.x.
  • [32] A C Rodrigues;D C Cara;S H Fretez;F Q Cunha;E C Vieira;J R Nicoli;L Q Vieira. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice.. Journal of applied microbiology(IF=3.2). 2000. PMID:11021572. DOI: 10.1046/j.1365-2672.2000.01128.x.
  • [33] Binxin Cui;Lin Lin;Bangmao Wang;Wentian Liu;Chao Sun. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?. Pharmacological research(IF=10.5). 2022. PMID:34883213. DOI: 10.1016/j.phrs.2021.106022.
  • [34] Bei Li;Haibo Zhang;Linlin Shi;Rong Li;Yanan Luo;Yun Deng;Shihan Li;Ruizhen Li;Zhi Liu. Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice.. Food & function(IF=5.4). 2022. PMID:34878454. DOI: 10.1039/d1fo02752b.
  • [35] Paul Forsythe. Probiotics and lung diseases.. Chest(IF=8.6). 2011. PMID:21467057. DOI: 10.1378/chest.10-1861.
  • [36] Eirini Filidou;Leonidas Kandilogiannakis;Anne Shrewsbury;George Kolios;Katerina Kotzampassi. Probiotics: Shaping the gut immunological responses.. World journal of gastroenterology(IF=5.4). 2024. PMID:38681982. DOI: 10.3748/wjg.v30.i15.2096.
  • [37] Jing Ren;Huimin Li;Guixing Zeng;Boxian Pang;Qiuhong Wang;Junping Wei. Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?. Frontiers in pharmacology(IF=4.8). 2023. PMID:37324466. DOI: 10.3389/fphar.2023.1178596.
  • [38] Mahsa Beikmohammadi;Saba Halimi;Najaf Allahyari Fard;Weijie Wen. Therapeutic Potential of Probiotics: A Review of Their Role in Modulating Inflammation.. Probiotics and antimicrobial proteins(IF=4.4). 2025. PMID:40465090. DOI: 10.1007/s12602-025-10609-z.
  • [39] Julio Plaza-Díaz;Francisco Javier Ruiz-Ojeda;Laura Maria Vilchez-Padial;Angel Gil. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.. Nutrients(IF=5.0). 2017. PMID:28555037. DOI: 10.3390/nu9060555.
  • [40] Charlotte D'Mello;Natalie Ronaghan;Raza Zaheer;Michael Dicay;Tai Le;Wallace K MacNaughton;Michael G Surrette;Mark G Swain. Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain.. The Journal of neuroscience : the official journal of the Society for Neuroscience(IF=4.0). 2015. PMID:26224864. DOI: 10.1523/JNEUROSCI.0575-15.2015.
  • [41] Andrea Piccioni;Sara Cicchinelli;Federico Valletta;Giulio De Luca;Yaroslava Longhitano;Marcello Candelli;Veronica Ojetti;Francesco Sardeo;Simone Navarra;Marcello Covino;Francesco Franceschi. Gut Microbiota and Autoimmune Diseases: A Charming Real World Together with Probiotics.. Current medicinal chemistry(IF=3.5). 2022. PMID:34551690. DOI: 10.2174/0929867328666210922161913.
  • [42] Kah Onn Kwok;Lisa R Fries;Irma Silva-Zolezzi;Sagar K Thakkar;Alison Iroz;Carine Blanchard. Effects of Probiotic Intervention on Markers of Inflammation and Health Outcomes in Women of Reproductive Age and Their Children.. Frontiers in nutrition(IF=5.1). 2022. PMID:35734372. DOI: 10.3389/fnut.2022.889040.
  • [43] Quancen Li;Na Li;Wenwen Cai;Meifang Xiao;Bin Liu;Feng Zeng. Fermented natural product targeting gut microbiota regulate immunity and anti-inflammatory activity: A possible way to prevent COVID-19 in daily diet.. Journal of functional foods(IF=4.0). 2022. PMID:36034155. DOI: 10.1016/j.jff.2022.105229.
  • [44] K L Erickson;N E Hubbard. Probiotic immunomodulation in health and disease.. The Journal of nutrition(IF=3.8). 2000. PMID:10721915. DOI: 10.1093/jn/130.2.403S.
  • [45] Naheed Mojgani;Sumel Ashique;Mehran Moradi;Masoumeh Bagheri;Ashish Garg;Monika Kaushik;Md Sadique Hussain;Sabina Yasmin;Mohammad Yousuf Ansari. Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention.. Probiotics and antimicrobial proteins(IF=4.4). 2025. PMID:39964413. DOI: 10.1007/s12602-025-10477-7.
  • [46] M Meijerink;A Mercenier;J M Wells. Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials.. Beneficial microbes(IF=3.1). 2013. PMID:23434949. DOI: 10.3920/BM2012.0035.
  • [47] Ewa Carolak;Joanna Czajkowska;Adrianna Stypułkowska;Wiktoria Waszczuk;Agata Dutkiewicz;Krzysztof Grzymajlo. Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens.. Gut microbes(IF=11.0). 2025. PMID:40530826. DOI: 10.1080/19490976.2025.2519696.
  • [48] Martin Manuel Palomar;Carolina Maldonado Galdeano;Gabriela Perdigón. Influence of a probiotic lactobacillus strain on the intestinal ecosystem in a stress model mouse.. Brain, behavior, and immunity(IF=7.6). 2014. PMID:24016865. DOI: .
  • [49] Xinzhou Wang;Peng Zhang;Xin Zhang. Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity.. Molecules (Basel, Switzerland)(IF=4.6). 2021. PMID:34641619. DOI: 10.3390/molecules26196076.
  • [50] Harpreet Kaur;Syed Azmal Ali. Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation.. Food & function(IF=5.4). 2022. PMID:35766374. DOI: 10.1039/d2fo00911k.
  • [51] E Isolauri;Y Sütas;P Kankaanpää;H Arvilommi;S Salminen. Probiotics: effects on immunity.. The American journal of clinical nutrition(IF=6.9). 2001. PMID:11157355. DOI: 10.1093/ajcn/73.2.444s.
  • [52] Nima Montazeri-Najafabady. From One-Size-Fits-All to Precision Medicine: The Promise of Personalized Probiotics.. Probiotics and antimicrobial proteins(IF=4.4). 2025. PMID:41160388. DOI: 10.1007/s12602-025-10815-9.
  • [53] Faisal Al-Akayleh;Ahmed S A Ali Agha;Mayyas Al-Remawi;Ibrahim S I Al-Adham;Saifeddin Daadoue;Anagheem Alsisan;Dana Khattab;Doha Malath;Haneen Salameh;Maya Al-Betar;Motaz AlSakka;Phillip J Collier. What We Know About the Actual Role of Traditional Probiotics in Health and Disease.. Probiotics and antimicrobial proteins(IF=4.4). 2024. PMID:38700762. DOI: 10.1007/s12602-024-10275-7.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Probiotics · Immune Function · Gut Microbiota · Cytokines · Immune Cells

© 2025 MaltSci